REAL-WORLD USE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN US PATIENTS WITH ANKYLOSING SPONDYLITIS: PERSISTENCE, FACTORS ASSOCIATED WITH DISCONTINUATION, AND DOSING PATTERNS

被引：0
|
作者：
Dubreuil, M. [1 ]
Walsh, J. A. [2 ,3 ]
Deodhar, A. [4 ]
Gensler, L. S. [5 ]
Curtis, J. R. [6 ]
Anjohrin, S. [7 ]
Pilipczuk, O. [8 ]
Tepie, Feudjo M. [9 ]
Beaty, S. [8 ]
Morup, M. [10 ]
Taieb, V [11 ]
Welby, S. [8 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Salt Lake City Vet Affairs Hlth, Salt Lake City, UT USA
[3] Univ Utah Hlth, Salt Lake City, UT USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Univ Alabama Birmingham, Birmingham, AL USA
[7] UCB Pharma, Tallahassee, FL USA
[8] UCB Pharma, Brussels, Belgium
[9] UCB Pharma, Smyrna, GA USA
[10] UCB Pharma, Copenhagen, Denmark
[11] UCB Pharma, Colombes, France
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD136
引用
收藏
页码：S386 / S387
页数：2
相关论文
共 50 条
  • [1] REAL-WORLD USAGE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH PSORIATIC ARTHRITIS IN GERMANY
    Song, J.
    Anjohrin, S.
    Abe, C.
    Banefelt, J.
    Rieem, Dun A.
    Picker, N.
    Kromer, D.
    Fuchs, A.
    Hahn, P.
    Welby, S.
    VALUE IN HEALTH, 2023, 26 (12) : S305 - S305
  • [2] REAL-WORLD USAGE OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS IN GERMANY
    Anjohrin, S.
    Song, J.
    Abe, C.
    Banefelt, J.
    Dun, Rieem A.
    Picker, N.
    Kromer, D.
    Fuchs, A.
    Hahn, P.
    Welby, S.
    VALUE IN HEALTH, 2023, 26 (12) : S300 - S300
  • [3] Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis
    Haibel, H.
    Specker, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S159 - S163
  • [4] Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia
    Donges, E.
    Staatz, C. E.
    Benham, H.
    Kubler, P.
    Hollingworth, S. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : 907 - 912
  • [5] REAL WORLD TREATMENT USAGE OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN US PATIENTS WITH PSORIATIC ARTHRITIS: PERSISTENCE, FACTORS ASSOCIATED WITH NON-PERSISTENCE, AND DOSING PATTERNS
    Welby, S.
    Song, J.
    Lu, C.
    Pilipczuk, O.
    Willems, D.
    Beaty, S.
    Eells, J.
    Tepie, M. Feudjo
    VALUE IN HEALTH, 2023, 26 (06) : S394 - S395
  • [6] Add-On Effects of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs in Ankylosing Spondylitis: Data from a Real-World Registered Study in China
    Man, Siliang
    Ji, Xiaojian
    Wang, Yiwen
    Ma, Yingpei
    Hu, Zhengyuan
    Zhu, Jian
    Zhang, Jianglin
    Huang, Feng
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [7] Treatment Response to Biological Disease-modifying Anti-rheumatic Drugs Is Associated with Favorable Changes of the Body Composition in Patients with Ankylosing Spondylitis
    Rodriguez, Valeria Rios
    Protopopov, Mikhail
    Proft, Fabian
    Rademacher, Judith
    Muche, Burkhard
    Weber, Anne-Katrin
    Lueders, Susanne
    Haibel, Hildrun
    Verba, Maryna
    Sieper, Joachim
    Poddubnyy, Denis
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] TREATMENT PATTERNS, PERSISTENCE, AND DURABILITY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS)
    Dore, Robin K.
    Antonova, Jenya
    Burudpakdee, Chakkarin
    Wang, Xin
    Ozbay, Burak
    Genovese, Mark C.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1135 - 1136
  • [9] TREATMENT RESPONSE TO BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IS ASSOCIATED WITH FAVORABLE CHANGES OF THE BODY COMPOSITION IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Rodriguez, V. Rios
    Protopopov, M.
    Proft, F.
    Rademacher, J.
    Muche, B.
    Weber, A. K.
    Luders, S.
    Haibel, H.
    Verba, M.
    Sieper, J.
    Poddubnyy, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 730 - 731
  • [10] Impact of Body Composition Measures on the Response to Biological Disease-modifying Anti-rheumatic Drugs in Patients with Ankylosing Spondylitis
    Rodriguez, Valeria Rios
    Protopopov, Mikhail
    Proft, Fabian
    Rademacher, Judith
    Muche, Burkhard
    Weber, Anne-Katrin
    Lueders, Susanne
    Haibel, Hildrun
    Verba, Maryna
    Sieper, Joachim
    Poddubnyy, Denis
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345